-+ 0.00%
-+ 0.00%
-+ 0.00%

ATOSSA THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR (Z)-ENDOXIFEN FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Reuters·01/16/2026 21:40:00

Please log in to view news